NCT05413044View on ClinicalTrials.gov

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register

Active, not recruitingOBSERVATIONAL
Enrollment

4,300

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

November 26, 2025

Study Completion Date

January 30, 2026

Conditions
Rheumatoid ArthritisPsoriatic Arthritis
Trial Locations (1)

08540

Local Institution, Princeton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05413044 - A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register | Biotech Hunter | Biotech Hunter